Your browser doesn't support javascript.
loading
FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer.
Chung, Wei-Pang; Huang, Wei-Lun; Liao, Wei-An; Hung, Chun-Hua; Chiang, Chi-Wu; Cheung, Chun Hei Antonio; Su, Wu-Chou.
Afiliação
  • Chung WP; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Huang WL; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Liao WA; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
  • Hung CH; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
  • Chiang CW; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Cheung CHA; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Su WC; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.
Sci Rep ; 12(1): 241, 2022 01 07.
Article em En | MEDLINE | ID: mdl-34997132
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Cloridrato de Fingolimode Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Cloridrato de Fingolimode Idioma: En Ano de publicação: 2022 Tipo de documento: Article